Core Insights - Thermo Fisher is acquiring Clario, a privately held data management company, for approximately $8.9 billion in cash and future payments, which will enhance its position in digital health and clinical trial research [1] Company Summary - The acquisition of Clario will strengthen Thermo Fisher's presence in the life sciences sector, particularly in the areas of digital health and clinical trial research [1]

Clinical trial recruitment platform Trially has raised $4.7m in a seed funding round and introduced its agentic AI solution, Margo, designed to increase study enrolment by converting patient matches into actual subjects. The company said that 86% of trials experience delays due to recruitment issues, resulting in the pharma industry incurring significant losses daily, while patients endure lengthy waits for potentially life-saving treatments. As the first fully integrated AI platform designed to address ...